About Starget Pharma
Starget Pharma is a company based in Ramat Hasharon (Israel) founded in 2019 by Ronen Kalmanson and Sigal Kalmanson Cusnir. Starget Pharma has raised $31.47 million across 3 funding rounds from investors including Ilex Medical and Cancer Focus Fund. Starget Pharma offers products and services including Smart Targeted Radioligands and Peptides Backbone Dynamics Technology. Starget Pharma operates in a competitive market with competitors including RefleXion, Alpha Tau Medical, Mevion Medical Systems, ZAP-X and Leo Cancer Care, among others.
- Headquarter Ramat Hasharon, Israel
- Founders Ronen Kalmanson, Sigal Kalmanson Cusnir
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$31.47 M (USD)
in 3 rounds
-
Latest Funding Round
$16.37 M (USD), Series B
Jan 20, 2026
-
Investors
Ilex Medical
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Starget Pharma
Starget Pharma offers a comprehensive portfolio of products and services, including Smart Targeted Radioligands and Peptides Backbone Dynamics Technology.
Radioligands that deliver radiation to cancer cells with precision oncology focus.
Technology for designing peptide-based radioligands for cancer treatment.
People of Starget Pharma
Unlock access to complete
Unlock access to complete
Funding Insights of Starget Pharma
Starget Pharma has successfully raised a total of $31.47M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $16.37 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Starget Pharma
Starget Pharma has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Ilex Medical and Cancer Focus Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
An investment fund focused on oncology therapies is managed.
|
Locked | Locked | Locked | |
|
Plastic injection molded components and wiring solutions are manufactured.
|
Locked | Locked | Locked |
Investor details for Starget Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Starget Pharma
Investment portfolio details for Starget Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Starget Pharma
Detailed financials for Starget Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Starget Pharma Comparisons
Peer comparison for Starget Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Starget Pharma
Starget Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RefleXion, Alpha Tau Medical, Mevion Medical Systems, ZAP-X and Leo Cancer Care, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biology-guided radiotherapy systems are provided for cancer treatment.
|
|
| Locked | Locked | Locked |
Radiotherapy technique for solid tumors is developed using alpha-emitting seeds.
|
|
| Locked | Locked | Locked |
Proton therapy systems are supplied for cancer radiation treatment.
|
|
| Locked | Locked | Locked |
Developer of gyroscopic radiosurgery platform
|
|
| Locked | Locked | Locked |
Advanced radiotherapy devices for cancer treatment are developed.
|
Detailed competitors of Starget Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Starget Pharma
Complete news archive for Starget Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Starget Pharma
Starget Pharma was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Starget Pharma is headquartered in Ramat Hasharon, Israel. It is registered at Ramat Hasharon, Tel Aviv District, Israel.
Sigal Kalmanson Cusnir is the current CEO of Starget Pharma. They have also founded this company.
Starget Pharma is a funded company, having raised a total of $31.47M across 3 funding rounds to date.
Starget Pharma was founded in 2019 in Ramat Hasharon, Israel, within the radiopharmaceutical sector. Technologies for targeted delivery of radioactive isotopes to solid tumors are developed for cancer diagnosis and therapy. Molecules are researched as vectors to enable precise transfer of isotopes to cancerous sites. Operations focus on advancing these innovations for clinical applications in oncology.
Starget Pharma's top competitors include RefleXion, Alpha Tau Medical and ABK Biomedical.
Starget Pharma offers Smart Targeted Radioligands and Peptides Backbone Dynamics Technology.
Starget Pharma has 2 investors. Key investors include Ilex Medical, and Cancer Focus Fund.